Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.
Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente
This book examines the role of technology-assisted interventions for substance use disorders (SUD). It considers this topic alongside the dramatic increase in SUDs and associated harm in the United States’ past decade.
Chapters relay the impact and effectiveness of technology-assisted interventions, which include telemedicine, assisted therapies, and support. These treatments not only offer practical care but also address the issue of access to care, particularly in the wake of the global pandemic (COVID-19). Organized into three sections, section one covers the use of telemedicine and technology-assisted therapies as it relates to the treatment of various SUDs, achieving recovery and maintenance. Each chapter will expand on a specific aspect of technology-assisted intervention. Following this, section two explores the differences in technology-assisted interventions and approaches while taking into account age, gender, sexuality, identity, and psychosocial factors. This section will be divided into chapters on children and adolescents, women and pregnancy, older adults, LGBTQIA+, and professionals. To close the book, section three discusses the media impact on SUDs and the legal technology adopted by drug courts.
Unique and timely, Technology-Assisted Interventions for Substance Use Disorders is an invaluable resource to learners and practitioners in the field. It provides a concise yet comprehensive summary of the current status of the field that will help guide the implementation of technology-assisted interventions for all SUDs into practice and stimulate investigative efforts.
Jonathan Avery, M.D.
Vice Chair, Addiction Psychiatry
Stephen P. Tobin and Dr. Arnold M. Cooper Associate Professor in Consultation-Liaison Psychiatry
Program Director, Addiction Psychiatry Fellowship
Program Director, Opioid Overdose Prevention Program
Weill Cornell Medicine I New York-Presbyterian
New York, NY
Mashal Khan, M.D
Assistant Professor of Clinical Psychiatry
Asst. Program Director, Addiction Psychiatry FellowshipAssistant Professor of Clinical Psychiatry
Weill Cornell Medicine I New York-Presbyterian
New York, NY.
Il sito utilizza cookie ed altri strumenti di tracciamento che raccolgono informazioni dal dispositivo dell’utente. Oltre ai cookie tecnici ed analitici aggregati, strettamente necessari per il funzionamento di questo sito web, previo consenso dell’utente possono essere installati cookie di profilazione e marketing e cookie dei social media. Cliccando su “Accetto tutti i cookie” saranno attivate tutte le categorie di cookie. Per accettare solo deterninate categorie di cookie, cliccare invece su “Impostazioni cookie”. Chiudendo il banner o continuando a navigare saranno installati solo cookie tecnici. Per maggiori dettagli, consultare la Cookie Policy.